J&J no liability
This article was originally published in The Tan Sheet
A California jury cleared McNeil Consumer & Specialty Pharmaceuticals on July 17 of liability in a lawsuit filed by 11-year-old Sabrina Brierton Johnson, who suffered Stevens-Johnson syndrome after using Children's Motrin. Johnson, who is now blind, will appeal her case, which alleges the Johnson & Johnson division failed to adequately warn on its product label that the ibuprofen in Motrin can trigger a rare allergic reaction that causes blindness and even death, according to lawyers at Greene Broillet & Wheeler, which represented the girl and her parents in the case litigated in Los Angeles Superior Court ("The Tan Sheet" June 16, 2008, p. 9)...
You may also be interested in...
A lawsuit that alleges Children's Motrin with ibuprofen caused a girl's blindness wants McNeil Consumer & Specialty Pharmaceuticals to clearly list all potential serious adverse reactions on the product's label and compensate the child
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.